164313
3-Methoxytyramine hydrochloride
96%
Synonym(s):
3-MT, 3-Methoxy-4-hydroxyphenethylamine hydrochloride, 4-(2-Aminoethyl)-2-methoxyphenol hydrochloride
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3OC6H3-4-(OH)CH2CH2NH2·HCl
CAS Number:
Molecular Weight:
203.67
EC Number:
216-035-1
UNSPSC Code:
12352200
PubChem Substance ID:
Beilstein/REAXYS Number:
3631283
MDL number:
assay
96%
mp
213-215 °C (lit.)
SMILES string
Cl[H].COc1cc(CCN)ccc1O
InChI
1S/C9H13NO2.ClH/c1-12-9-6-7(4-5-10)2-3-8(9)11;/h2-3,6,11H,4-5,10H2,1H3;1H
InChI key
AWRIOTVUTPLWLF-UHFFFAOYSA-N
General description
A major metabolite of L-DOPA.
Still not finding the right product?
Explore all of our products under 3-Methoxytyramine hydrochloride
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Moon Chul Jung et al.
Analytical chemistry, 78(6), 1761-1768 (2006-03-16)
The photoluminescence-following electron-transfer (PFET) technique, developed in our laboratory, is a sensitive chromatographic detection method for oxidizable analytes. Because the oxidations are homogeneous, the technique avoids the problem of electrode fouling. A liquid-phase oxidant reacts with the electrochemically active analytes
Wilhelmina H A de Jong et al.
The Journal of clinical endocrinology and metabolism, 94(8), 2841-2849 (2009-07-02)
Measurements of the 3-O-methylated metabolites of catecholamines [metanephrines (MNs)] in plasma or urine are recommended for diagnosis of pheochromocytoma. It is unclear whether these tests are susceptible to dietary influences. The aim of the study was to determine the short-term
Anouk N A Van Der Horst-Schrivers et al.
Anticancer research, 30(12), 5153-5158 (2010-12-29)
This study aimed to determine the prevalence of excess dopamine in relation to clinical symptoms and nuclear imaging in head and neck paraganglioma (PGL) patients. Thirty-six consecutive patients with head and neck PGLs, evaluated between 1993 and 2009, were included.